Bid To Down-Classify Bone Growth Stimulators Lacks Merit, Rivals Say
This article was originally published in The Gray Sheet
Executive Summary
RS Medical's petition to down-classify "non-invasive" bone growth stimulators offers inadequate safeguards to warrant easing regulatory oversight, current manufacturers of the products assert